Bibliography
- Turner JA, Sears JM, Loeser JD. Programmable intrathecal opioid delivery systems for chronic no cancer pain: a systematic review of effectiveness and complications. Clin J Pain 2007;23:180-95
- Williams JE, Louw G, Towlerton G. Intrathecal pumps for giving opioids in chronic pain: a systematic review. Health Technol Assess 2000;4:1-65
- Hassenbusch SJ, Portenoy RK, Cousins M, et al. Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery – report of an expert panel. J Pain Symptom Manage 2004;27:540-63
- Deer T, Krames ES, Hassenbusch SJ, et al. Polyanalgesic Consensus Conference 2007: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary panel. Neuromodulation 2007;10:300-28
- Koltz U. Ziconotide – a novel neuron-specific calcium channel blocker for the intrathecal treatment of severe chronic pain a short review. Int J Clin Pharm Ther 2006;44:478-83
- Available from: http://www.portfolio.mvm.ed.ac.uk/studentwebs/session2/group13/snails.html.
- Olivera BM, Teichert RW: Diversity of the neurotoxic peptides. Mol Intervent 2007;7:251-60
- Product information. ziconotide. In: Investigator's Brochure. San Diego CA: Elan Pharmaceuticals, Inc.; 2004
- Wermeling DP. Ziconotide, an intrathecally administered N-type calcium channel antagonist for the treatment of chronic pain. Pharmacotherapy 2005;25:1084-94
- Prommer EE. Ziconotide: can we use it in palliative care? Am J Hospice Palliat Med 2005;22:369-74
- Wallace MS. Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain. Expert Rev Neurother 2006;6:1423-8
- Available from: http://www.thomsonhc.com/hcs/librarian/PFPUI/TP1mNbz2nkQ9Rn (Micromedex Healthcare Series through Texas Tech University HSC library: keyword ziconotide)
- Available from: http://www.pbm.va.gov/DrugMonograph.aspx
- Webster LR, Fakata KL, Charapata S, et al. Open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of morphine in patients receiving ziconotide for severe chronic pain. Pain Med 2008;9:282-90
- Shields D, Montenegro R, Ragusa M. Chemical stability of admixtures combining ziconotide with morphine and hydromorphone during simulated intrathecal administration. Neuromodulation 2005;8:257-63
- Shields D, Montenegro R, Aclan J. Chemical stability of an admixture combining ziconotide and bupivacaine during simulated intrathecal administration. Neuromodulation 2007;10(Suppl 1):1-5
- Shields D, Montenegro R. Chemical stability of ziconotide–clonidine hydrochloride admixture with and without morphine sulfate during simulated intrathecal administration. Neuromodulation 2007;10(Suppl 1):6-11
- Shields D, Montenegro R, Aclan J. Chemical stability of an admixtures combining ziconotide with baclofen during simulated intrathecal administration. Neuromodulation 2007;10(Suppl 1):12-17
- Staats PS, Yearwood T, Charapata SG, et al. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial. JAMA 2004;291:63-70
- Atanassoff PG, Hartmannsgruber MW, Thrasher J, et al. Ziconotide, a new n-type calcium channel blocker, administered intrathecally for acute postoperative pain. Reg Anesth Pain Med 2000;25:274-8
- Ridgeway B, Wallace MS, Gerayli A. Ziconotide for the treatment of severe spasticity after spinal cord injury. Pain 2000;85:287-9
- Rauck RL, Wallace MS, Leong MS, et al. A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain. J Pain Symptom Manage 2006;31:393-406
- Wallace MS, Kosek PS, Staats P, et al. Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain. Pain Med 2008;9:271-281
- Stanton-Hicks M, Kapural L. An effective treatment of severe complex regional pain syndrome type I in a child using high doses of intrathecal ziconotide. J Pain Symptom Manage 2006;32:509-11
- Wermeling DP, Berger JR. Ziconotide infusion for severe chronic pain: case series of patients with neuropathic pain. Pharmacotherapy 2006;26:396-402
- Mcguire D, Bowersox S, Fellman JD, et al. Sympatholysis after neuron-specific, n-type, voltage-sensitive calcium channel blockade: first demonstration of n-channel function in humans. J Cardiovasc Pharmacol 1997;30:400-3
- Available from: http://www.neuromed.com/news/pressr.php?nr=15&txt= &pyear=2006